HBV受体NTCP的功能缺失S267F变异降低人类HBV感染与疾病进展风险
在1117例中国汉族人群中,HBV抵抗的健康对照S267F(T等位基因)频率为4.0%,高于HBV感染患者的1.5%,OR 0.32(95%CI 0.15-0.68;P=.003;显性模型)。267F变异基因型还与肝硬化风险降低(OR 0.15,95%CI 0.03-0.70)和HCC风险降低(OR 0.21,95%CI 0.062-0.72)相关;S267F与HBV自发清除无关联。
要点
- S267F(T等位基因)频率在HBV抵抗健康对照中为4.0%,高于HBV感染患者的1.5%(OR 0.32,95%CI 0.15-0.68;P=.003)。
- 267F变异基因型与肝硬化风险降低相关(OR 0.15,95%CI 0.03-0.70)。
- 267F变异基因型与HCC风险降低相关(OR 0.21,95%CI 0.062-0.72);S267F与HBV自发清除无关联。
核心结论
- HBV细胞进入受体NTCP的S267F变异与HBV感染抵抗增加相关,并与慢性HBV感染者肝硬化与肝癌风险降低相关。
研究设计与样本
- 在1117例具有不同HBV感染结局的中国汉族患者中,采用多变量逻辑回归分析检测S267F的效应。
主要发现
- S267F(T等位基因)在HBV抵抗健康对照(n=179)中频率为4.0%,高于HBV感染患者(n=648)的1.5%,OR 0.32(95%CI 0.15-0.68;P=.003;显性模型)。
- 267F变异基因型与慢性HBV感染(n=202,3.0%)相比,肝硬化(n=192,0.5%)风险OR 0.15(95%CI 0.03-0.70),HCC(n=258,1.0%)风险OR 0.21(95%CI 0.062-0.72)。
- S267F变异与HBV自发清除无关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sodium taurocholate cotransporting polypeptide (NTCP, SLC10A1) is a hepatocyte receptor for hepatitis B virus (HBV) infection. The natural NTCP S267F variant causes loss of NTCP HBV receptor function. We assessed the association of S267F with HBV resistance, HBV infection clearance, and HBV-related cirrhosis and hepatocellular carcinoma (HCC). METHODS: We tested the effects of S267F in 1117 Han Chinese patients with various HBV infection outcomes using multivariate logistic regression analysis. RESULTS: The frequency of S267F (T allele) was higher in HBV-resistant healthy controls (n = 179, 4.0%) compared to HBV-infected patients (n = 648, 1.5%); odds ratio (OR) 0.32 (95% confidence interval [CI] 0.15-0.68; P = .003; dominant model). 267F variant genotypes were also associated with reduced risk for cirrhosis (n = 192, 0.5%) and HCC (n = 258, 1.0%) compared to those with chronic HBV infection (n = 202, 3.0%); OR 0.15 (95% CI, 0.03-0.70) and OR 0.21 (95% CI, 0.062-0.72), respectively. There was no association of the S267F variant with spontaneous HBV clearance. CONCLUSION: The S267F variant for the HBV cell-entry receptor NTCP was associated with increased resistance to HBV infection and decreased risk for cirrhosis and liver cancer among those with chronic HBV infection.
引用
- An P, Zeng Z, Winkler CA, et al. The Loss-of-Function S267F Variant in HBV Receptor NTCP Reduces Human Risk for HBV Infection and Disease Progression. J Infect Dis. 2018. PMID: 29905807. doi:10.1093/infdis/jiy355
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。